Aurobindo Pharma informs about press release

09 Dec 2020 Evaluate

Aurobindo Pharma has informed that it has enclosed a copy of the Press Release on 9th December 2020 that is being issued by the Company in connection with USFDA approval received by the Company for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1303.20 -10.55 (-0.80%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×